Carboplatin

colony stimulating factor 3 ; Homo sapiens







23 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31149552 Acute arteritis after G-CSF administration. 2019 Apr 1
2 27749622 Plerixafor mobilization of peripheral blood hematopoietic progenitors to support further high-dose chemotherapy cycles in a patient with germ-cell tumor relapsing after previous tandem high-dose chemotherapy and hematopoietic cell transplantation: report of a case. 2017 Feb 1
3 29158911 A retrospective evaluation of activity of gemcitabine/platinum regimens in the treatment of recurrent ovarian cancer. 2017 2
4 25186439 Model-based approach to early predict prolonged high grade neutropenia in carboplatin-treated patients and guide G-CSF prophylactic treatment. 2015 Feb 1
5 26049123 Phase II study of weekly paclitaxel/carboplatin in combination with prophylactic G-CSF in the treatment of gynecologic cancers: A study in 108 patients by the Belgian Gynaecological Oncology Group. 2015 Aug 1
6 25648659 Comparison of Therapeutic G-CSF Cycles and Prophylactic G-CSF Cycles in Patients Receiving Paclitaxel and Carboplatin Combination Chemotherapy for Ovarian Cancer: A Retrospective Study Report. 2014 3
7 23801085 Model-based approach to describe G-CSF effects in carboplatin-treated cancer patients. 2013 Nov 1
8 18455782 Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study. 2008 Jul 1
9 18644619 Paclitaxel, topotecan, and carboplatin in metastatic endometrial cancinoma: a Hellenic Co-operative Oncology Group (HeCOG) study. 2008 Oct 1
10 17873305 Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II study. 2007 1
11 16781005 A combination chemotherapy of carboplatin and irinotecan with granulocyte colony-stimulating factor (G-CSF) support in elderly patients with small cell lung cancer. 2006 Aug 1
12 12045462 Phase I study of carboplatin, irinotecan and docetaxel on a divided schedule with recombinant human granulocyte colony stimulating factor support in patients with stage IIIB or IV non-small cell lung cancer. 2002 Jun 1
13 11115564 Prognostic results of cisplatin IP and carboplatin IV with G-CSF in patients with ovarian cancer. 2001 Jan-Feb 1
14 11142689 Phase I study of carboplatin, docetaxel and irinotecan with recombinant human granulocyte colony stimulating factor support in patients with advanced non-small cell lung cancer. 2000 Nov 1
15 10355578 Pharmacokinetically guided dose escalation of carboplatin in epithelial ovarian cancer: effect on drug-plasma AUC and peripheral blood drug-DNA adduct levels. 1999 Mar 1
16 9215604 Efficacy of carboplatin plus primary prophylactic filgrastim (granulocyte colony stimulating factor) in relapsed ovarian cancer: a study of the Gynecologic Oncology Group of the Comprehensive Cancer Center Limburg. 1997 Jun 1
17 9364542 Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer. 1997 Aug 3
18 9377855 Phase I-II study of dose intensified chemotherapy with filgrastim and thymopentin in patients with advanced cancer. 1997 May-Jun 1
19 8622027 Phase I study of pharmacologically based dosing of carboplatin with filgrastim support in women with epithelial ovarian cancer. 1996 Mar 4
20 8630941 Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma. A study of the Lung Cancer Study Group of West Japan. 1996 Jan 1 2
21 8826913 Phase I/II study of carboplatin and oral etoposide with granulocyte-colony stimulating factor in advanced nonsmall cell lung cancer. 1995 Apr 1 2
22 7527590 Carboplatin and granulocyte colony-stimulating factor as first-line treatment for epithelial ovarian cancer: a phase I dose-intensity escalation study. 1994 Oct 1
23 7541325 [Clinical study of recombinant human granulocyte colony-stimulating factor (RHG-CSF) on leucopenia induced by chemotherapy with CE regimen on lung cancer patients]. 1994 Nov 1